First-half revenue rises 25.6%, but operating cash flow turns negative

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionNegative Operating CashflowResults View source PDF Explain this filing

STYRENIX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-9.0%Reaction day

₹1968.00

prior close

₹1943.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Specialty Chemicals peers, median of 99sector+0.4%-9.4% vs sector

On the reaction day the stock moved 9.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-6.5

10m

-8.4

15m

-6.9

30m

-8.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-9.0pendingpending+0.4-9.4

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 99Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited standalone and consolidated results for Q2 and H1 ended September 30, 2026. The auditor found no material problems. Consolidated H1 revenue rose 25.6% to INR 1,558.39 crore from INR 1,240.89 crore. Standalone H1 profit after tax rose to INR 190.82 crore from INR 108.66 crore. Consolidated H1 operating cash flow was negative INR 64.83 crore. An overseas subsidiary posted a quarterly loss of INR 29.62 crore.

Likely market impact

Revenue and profit growth is positive, but negative operating cash flow and losses at an overseas subsidiary could weigh on shareholder sentiment.